MX2017007578A - Farmacoterapia para prevenir o tratar glaucoma. - Google Patents
Farmacoterapia para prevenir o tratar glaucoma.Info
- Publication number
- MX2017007578A MX2017007578A MX2017007578A MX2017007578A MX2017007578A MX 2017007578 A MX2017007578 A MX 2017007578A MX 2017007578 A MX2017007578 A MX 2017007578A MX 2017007578 A MX2017007578 A MX 2017007578A MX 2017007578 A MX2017007578 A MX 2017007578A
- Authority
- MX
- Mexico
- Prior art keywords
- preventing
- pharmacotherapy
- treating glaucoma
- glaucoma
- treating
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 3
- 238000001050 pharmacotherapy Methods 0.000 title abstract 2
- 206010030043 Ocular hypertension Diseases 0.000 abstract 1
- 239000002269 analeptic agent Substances 0.000 abstract 1
- 230000004410 intraocular pressure Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- QSKQVZWVLOIIEV-NSHDSACASA-N ripasudil Chemical compound C[C@H]1CNCCCN1S(=O)(=O)C1=CC=CC2=CN=CC(F)=C12 QSKQVZWVLOIIEV-NSHDSACASA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporciona una farmacoterapia para prevenir glaucoma o prevenir o tratar hipertensión ocular, la farmacoterapia proporciona una acción potente de disminución de presión intraocular con propiedades de acción rápidas y duración prolongada; una combinación de (S)-(-)-1-(4-fluoro-5-isoquinolinas ulfonilo)-2-metil-1,4-homopiperazina o una sal del mismo, o un solvato de (S)-(-)-1-(4-fluoro-5-isoquinolinasulfonilo)-2-metil-1, 4-homopiperazina o la sal del mismo y un agonista de a2 para prevenir o tratar glaucoma.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014252052 | 2014-12-12 | ||
| PCT/JP2015/084817 WO2016093348A1 (ja) | 2014-12-12 | 2015-12-11 | 緑内障を予防又は治療するための薬物療法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017007578A true MX2017007578A (es) | 2017-09-07 |
Family
ID=56107525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017007578A MX2017007578A (es) | 2014-12-12 | 2015-12-11 | Farmacoterapia para prevenir o tratar glaucoma. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20170360782A1 (es) |
| EP (1) | EP3231428B1 (es) |
| JP (1) | JP6612774B2 (es) |
| KR (1) | KR20170093816A (es) |
| CN (1) | CN106999500B (es) |
| BR (1) | BR112017012503A2 (es) |
| CA (1) | CA2970328A1 (es) |
| MX (1) | MX2017007578A (es) |
| MY (1) | MY181729A (es) |
| SG (1) | SG11201704701YA (es) |
| TW (1) | TWI699205B (es) |
| WO (1) | WO2016093348A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201704737SA (en) * | 2014-12-12 | 2017-07-28 | Kowa Co | Novel aqueous composition |
| US20170368075A1 (en) * | 2014-12-12 | 2017-12-28 | Kowa Company, Ltd. | Composition |
| US20200108064A1 (en) * | 2017-06-08 | 2020-04-09 | Eye Therapies, Llc | Low-dose brimonidine combinations and uses thereof |
| US20200197398A1 (en) * | 2017-06-08 | 2020-06-25 | Eye Therapies, Llc | Netarsudil and low-dose brimonidine combination and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI367098B (en) * | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
| MX2012008516A (es) * | 2010-01-21 | 2012-10-15 | Allergan Inc | Agonista alfa-2 adrenergico que tiene larga duracion de efecto de baja presion intraocular. |
| JP2012250953A (ja) * | 2011-06-06 | 2012-12-20 | Santen Pharmaceut Co Ltd | アデノシン誘導体とα２受容体作動薬の組合せ剤 |
| RU2014103544A (ru) * | 2011-07-20 | 2015-08-27 | Аллерган, Инк. | Комбинация фиксированных доз биматопроста и бримонидина |
| JP2013035802A (ja) * | 2011-08-10 | 2013-02-21 | D Western Therapeutics Institute Inc | 緑内障又は高眼圧症の予防又は治療剤 |
| SG11201704737SA (en) * | 2014-12-12 | 2017-07-28 | Kowa Co | Novel aqueous composition |
-
2015
- 2015-12-10 TW TW104141511A patent/TWI699205B/zh active
- 2015-12-11 US US15/533,157 patent/US20170360782A1/en not_active Abandoned
- 2015-12-11 SG SG11201704701YA patent/SG11201704701YA/en unknown
- 2015-12-11 CN CN201580067618.2A patent/CN106999500B/zh active Active
- 2015-12-11 BR BR112017012503-0A patent/BR112017012503A2/pt not_active IP Right Cessation
- 2015-12-11 EP EP15866838.4A patent/EP3231428B1/en active Active
- 2015-12-11 CA CA2970328A patent/CA2970328A1/en not_active Abandoned
- 2015-12-11 JP JP2016563750A patent/JP6612774B2/ja active Active
- 2015-12-11 MX MX2017007578A patent/MX2017007578A/es active IP Right Grant
- 2015-12-11 MY MYPI2017701971A patent/MY181729A/en unknown
- 2015-12-11 KR KR1020177014856A patent/KR20170093816A/ko not_active Ceased
- 2015-12-11 WO PCT/JP2015/084817 patent/WO2016093348A1/ja not_active Ceased
-
2019
- 2019-09-10 US US16/566,473 patent/US20200038397A1/en not_active Abandoned
-
2020
- 2020-06-11 US US16/898,920 patent/US20200297723A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20200297723A1 (en) | 2020-09-24 |
| KR20170093816A (ko) | 2017-08-16 |
| JP6612774B2 (ja) | 2019-11-27 |
| TWI699205B (zh) | 2020-07-21 |
| TW201628619A (zh) | 2016-08-16 |
| JPWO2016093348A1 (ja) | 2017-09-21 |
| CN106999500B (zh) | 2020-11-13 |
| SG11201704701YA (en) | 2017-07-28 |
| US20200038397A1 (en) | 2020-02-06 |
| EP3231428A4 (en) | 2018-08-01 |
| US20170360782A1 (en) | 2017-12-21 |
| CN106999500A (zh) | 2017-08-01 |
| BR112017012503A2 (pt) | 2018-11-13 |
| EP3231428B1 (en) | 2020-03-04 |
| MY181729A (en) | 2021-01-05 |
| EP3231428A1 (en) | 2017-10-18 |
| CA2970328A1 (en) | 2016-06-16 |
| WO2016093348A1 (ja) | 2016-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500658A1 (en) | Methods of treating intraocular pressure with activators of tie-2 | |
| IL279136A (en) | Eye microsurgical tools, systems and methods of use | |
| MX2020011560A (es) | Porcion del cartucho de un aparato y metodo de administracion transdermica de medicamentos. | |
| EP3240535A4 (en) | Ophthalmic solutions for glaucoma and conjunctivitis treatment | |
| PH12017550004A1 (en) | Heterocyclic derivatives and use thereof | |
| MX356648B (es) | Entrecruzamiento de tejido ocular. | |
| MY186271A (en) | Ophthalmic compositions and methods of use therefor | |
| IL249688B (en) | A flat, one-piece device for draining aqueous fluid from the eye | |
| IL273946A (en) | Sustained release implants to reduce intraocular pressure with extended duration of activity | |
| EP3173089A4 (en) | Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction | |
| HUE055940T2 (hu) | Lencsék intrastromális szaruhártya-beültetéshez | |
| EP3519044A4 (en) | SYSTEMS, DEVICE AND METHOD FOR CROSSLINKING CORNEAL TISSUE | |
| GB2541840B (en) | Ophthalmic composition for the treatment of ocular infection | |
| MX2017007578A (es) | Farmacoterapia para prevenir o tratar glaucoma. | |
| IL270362B (en) | Glaucoma treatment | |
| GB201607797D0 (en) | Glaucoma therapy | |
| EP3302382A4 (en) | IMPLANT FOR THE TREATMENT OF OCULAR DISEASE | |
| WO2015102000A3 (en) | Ophthalmic viscosurgical device | |
| UY33562A (es) | Agonistas de receptores de bradicinina y su utilización para el tratamiento de la hipertensión ocular y el glaucoma | |
| SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases | |
| PL3539533T3 (pl) | Kompozycja kropli do oczu do obniżania ciśnienia wewnątrzgałkowego | |
| GB2543233A (en) | Penetrator for a puncture communication tool and method | |
| WO2016055464A8 (en) | Ophthalmic compositions | |
| HK40035606A (en) | Sustained-release implants for lowering intraocular pressure with extended duration of effect | |
| HK40018988A (en) | Integrated aqueous shunt for glaucoma treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |